ÂÜÀòÂÒÂ×

Monica Forbes serves as Sesen Bio’s chief financial officer. Ms. Forbes brings more than 20 years of financial leadership experience to Sesen Bio, including prior experience leading the finance and administrative functions of late and commercial-stage public and private life science companies. Ms. Forbes most recently served as the chief financial officer of Nalpropion Pharmaceuticals where she led the integration of a newly acquired asset and supporting commercial team. Prior to that, Ms. Forbes served as the acting chief financial officer of Orexigen Therapeutics where she oversaw all finance and administrative operations for the publicly traded company and played a key role in the successful sale of the company. Prior to being appointed acting chief financial officer at Orexigen, Ms. Forbes held various leadership roles with expertise in financial planning and analysis, budgeting, forecasting and business development across companies such as AstraZeneca, Invitrogen, Ericsson and Qualcomm. Ms. Forbes holds a Bachelor of Science in Business Administration from San Diego State University.